Healthcare -
Biotechnology - NASDAQ - US
$ 7.735
-2.09 %
$ 383 M
Market Cap
-1.54
P/E
Price Target
Average
325.20%
Revenue Forecast
Estimate
94.10%
EBIT
Estimate
--18.03%
Net Income
Estimate
26.72%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
REGENXBIO Inc.
Wall Street analysts predict an average 1-year price target for RGNX of $32.9 , with forecasts ranging from
a
low of
$18 to a high of $40 .
RGNX Lowest Price Target
Wall Street Target
18 USD
132.71%
RGNX Average Price Target
Wall Street Target
32.9 USD
325.20%
RGNX Highest Price Target
Wall Street Target
40 USD
417.13%
REVENUE FORECAST
Revenue Forecast Chart RGNX
EBIT FORECAST
EBIT Forecast Chart RGNX
NET INCOME FORECAST
Net Income Chart RGNX